Summary
CVS Health Corporation (CVS) has announced a significant debt offering through an Underwriting Agreement dated May 30, 2023. The company intends to issue and sell a total of $5,000,000,000 in aggregate principal amount of various senior notes, with maturities ranging from 2029 to 2063 and coupon rates between 5.000% and 6.000%. This substantial capital raise, with net proceeds expected to be approximately $4,937,925,000 after expenses, is being conducted under a previously filed Registration Statement on Form S-3ASR. The closing of this transaction is anticipated on June 2, 2023, subject to standard closing conditions. Investors should note that this filing primarily concerns the debt issuance and does not provide updated financial performance figures.
Key Highlights
- 1CVS Health is raising $5 billion through the issuance of Senior Notes across multiple maturities.
- 2The notes have varying coupon rates, from 5.000% for the 2029 Notes to 6.000% for the 2063 Notes.
- 3The net proceeds from the offering are estimated to be approximately $4.94 billion.
- 4The debt issuance is being managed by a syndicate of prominent underwriters including Barclays, BofA Securities, Goldman Sachs, J.P. Morgan, and Wells Fargo.
- 5The offering is conducted under an effective Registration Statement filed on May 25, 2023.
- 6The closing of the note sale is expected on June 2, 2023, pending customary conditions.
- 7This 8-K filing relates to a debt financing event and does not disclose new operational or financial performance data.